Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGRX 4975 in Inguinal Hernia Repair
NCT00146198Phase 2Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of capsaicin in postoperative pain (2 arms), sponsored by AlgoRx Pharmaceuticals. Primary endpoint: Average daily VAS pain scores during the first week after surgery at 1 week. Started Sep 2005; status: completed.
02
Drugs
capsaicin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00146198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146198.